These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6289778)

  • 1. Immune response to a DNA free herpes simplex vaccine in man.
    Cappel R; Sprecher S; Rickaert F; de Cuyper F
    Arch Virol; 1982; 73(1):61-7. PubMed ID: 6289778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of a herpes simplex subunit vaccine.
    Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
    J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type-2 glycoprotein-subunit vaccine: tolerance and humoral and cellular responses in humans.
    Mertz GJ; Peterman G; Ashley R; Jourden JL; Salter D; Morrison L; McLean A; Corey L
    J Infect Dis; 1984 Aug; 150(2):242-9. PubMed ID: 6088648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
    Welch MJ; Ridgeway PH; Phillpotts RJ
    FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
    Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL
    Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to DNA free herpes simplex proteins in man.
    Cappel R; Sprecher S; de Cuyper F
    Dev Biol Stand; 1982; 52():345-50. PubMed ID: 6299843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal studies on the efficacy of vaccination against recurrent herpes.
    Scriba M
    Med Microbiol Immunol; 1982; 171(1):33-42. PubMed ID: 6289061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection.
    Mertz GJ; Ashley R; Burke RL; Benedetti J; Critchlow C; Jones CC; Corey L
    J Infect Dis; 1990 Apr; 161(4):653-60. PubMed ID: 2181031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
    Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
    Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
    Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunized with HSV subunit vaccines.
    Bernstein DI; Stanberry LR; Kappes JC; Burke RL; Myers MG
    J Infect Dis; 1988 Jun; 157(6):1178-86. PubMed ID: 2836519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences.
    Kutinová L; Benda R; Kalos Z; Dbalý V; Votruba T; Kvícalová E; Petrovská P; Doutlík S; Kamínková J; Domorázková E
    Vaccine; 1988 Jun; 6(3):223-8. PubMed ID: 2844031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody and cell-mediated immunity to a DNA free herpes simplex subunit vaccine.
    Cappel R; de Cuyper F; de Braekeleer J
    Dev Biol Stand; 1979; 43():381-5. PubMed ID: 230114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A; Merigan TC
    J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody reactivity with Skinner HSV vaccine.
    Muniu EM; Durham J; Shariff D; Hartley CE; Fuller A; Melling J; Wiblin C; Wilkins G; Buchan A; Skinner GR
    Med Microbiol Immunol; 1987; 176(6):315-27. PubMed ID: 2828898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine.
    Ashley R; Mertz G; Clark H; Schick M; Salter D; Corey L
    J Virol; 1985 Nov; 56(2):475-81. PubMed ID: 2997470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
    Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
    J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.